US FDA approves Leqembi® IQKLIK™ subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease

BioArctic Sweden

View original content:https://www.prnewswire.co.uk/news-releases/us-fda-approves-leqembi-iqklik-lecanemab-irmb-subcutaneous-injection-for-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease-302542433.html